Medicine News and Research

RSS

Media examine efforts to eradicate Guinea worm

Agence France-Presse reports on efforts to eradicate Guinea worm, a "painful water-borne parasite that can leave people weakened and sick for months every year" (2/17).

18 Feb 2010

BG Medicine, Merck collaborate in development of novel biomarker for lipid disorder management

BG Medicine, Inc. today announced that it has entered into a research collaboration with Merck, through a subsidiary, for the development and validation of a novel biomarker with potential application in the management of lipid disorders. BG Medicine will pursue development and validation of an immunoassay and investigate its clinical utility as a biomarker. If successful, BG Medicine plans to complete the development and validation studies and seek regulatory clearance for the test.

18 Feb 2010

Obesity doubles the risk of developing kidney stones: Study

Obesity in general nearly doubles the risk of developing kidney stones, but the degree of obesity doesn't appear to increase or decrease the risk one way or the other, a new study from Johns Hopkins shows.

18 Feb 2010

People who are happy and content are less likely to develop heart disease

People who are usually happy, enthusiastic and content are less likely to develop heart disease than those who tend not to be happy, according to a major new study published today (Thursday 18 February).

18 Feb 2010

AGHE to hold conference to discuss on gerontological and geriatric education and training

The Association for Gerontology in Higher Education - the educational branch of The Gerontological Society of America - will hold its 36th Annual Meeting and Educational Leadership Conference from March 4 to 7, 2010, at The Peppermill in Reno, NV. This conference provides a forum for professionals in the field of aging to present their work and share ideas about gerontological and geriatric education and training.

18 Feb 2010

Utah tries to improve state health insurance exhange; Mich. plans for doctor shortage

The Salt Lake Tribune: "State health reform got a boost Tuesday with House passage of a fix-it bill to improve the Utah Health Exchange, an online tool for purchasing health insurance. Pitched as a free-market approach to lowering costs for small businesses, the exchange has had limited success. Only 400 people are receiving health insurance in its experimental first stage. And some of its 66 plans are up to 130 percent more expensive than what some companies were already paying. That's because insurers are calculating premiums differently 'inside' and 'outside' the exchange, said House Speaker Dave Clark" (Stewart, 2/16).

17 Feb 2010

Sorafenib drug therapy can reduce the size of primary kidney tumors before surgery

More than 57,000 Americans face a diagnosis of kidney cancer each year. Now patients with advanced disease may soon have another treatment option. Physicians who conducted a pilot study at UNC Lineberger Comprehensive Cancer Center found that therapy before surgery with the drug sorafenib can reduce the size of large tumors and could be safely undertaken administered without adding significantly to the risks of surgery.

17 Feb 2010

New research units established for Japanese-German research collaboration

With its ten new Research Units, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is intensifying interdisciplinary and multiple-location collaboration among researchers pursuing specific scientific questions and new avenues of research.

17 Feb 2010

Ardiem Medical receives non-exclusive license to make and sell neuromodulation devices

Ardiem Medical Inc. has obtained a non-exclusive license to make and sell neuromodulation devices based on intellectual property developed at Case Western Reserve University's Department of Biomedical Engineering and the Functional Electrical Stimulation Center in Cleveland.

17 Feb 2010

NABsys to utilize $7M Series B funding for accelerating DNA sequencing platform development

NABsys Inc., the pioneer in electronic, solid-state DNA sequencing, today announced that it has received a $7 million investment as part of a Series B equity round led by Stata Venture Partners. The funding will be used to accelerate the development and commercialization of the company’s proprietary DNA sequencing platform, which leverages semiconductor technology to achieve the scope and scale required for full integration of genomics into medicine.

17 Feb 2010

FDA approved cannabis medicines needed for veterans to relieve symptoms of PTSD

Cannabis Science Inc., an emerging pharmaceutical cannabis company, is reviewing interim results of its survey from over 1400 people, US military veterans and others who responded to our PTSD survey. The survey is still available for a limited time online on the www.cannabisscience.com website for all those who still wish to participate.

17 Feb 2010

NCOA survey: Communication about safety of medical imaging for patients is often inadequate

Today, the National Council on Aging released the results of a national survey of older adults, caregivers and health care providers evaluating knowledge and awareness of medical imaging safety. The survey, which focused largely on electronic implantable device patients and their caregivers, reveals that communication about the safety of medical imaging for patients with these devices is often inadequate.

17 Feb 2010

AAFA launches national PSA on "Two Main Causes of Asthma"

The Asthma and Allergy Foundation of America (AAFA) is launching a national public service announcement (PSA) supported by GlaxoSmithKline titled "Two Main Causes of Asthma." The PSA goal is to communicate an important message to the millions of Americans with asthma: that treating the two main causes of asthma symptoms may help prevent symptoms before they begin. Asthma symptoms include coughing, wheezing, difficulty breathing and chest tightness.

17 Feb 2010

Eleven Biotherapeutics announces completion of $35M Series A funding

Eleven Biotherapeutics, a biopharmaceutical company focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics, announced today it has completed a $35 million Series A financing co-led by Flagship Ventures and Third Rock Ventures. Proceeds from the financing will be used to build the research and development and business development teams for Eleven Biotherapeutics, in addition to advancing the company’s portfolio of engineered proteins through clinical proof of concept.

17 Feb 2010

Low-income nations lack advanced e-health tools that can help them achieve better health outcomes

In an essay in the February 2010 issue of Health Affairs, a special issue of the journal devoted to global e-health, William Tierney, M.D., of Indiana University School of Medicine and the Regenstrief Institute, and colleagues, who like Dr. Tierney have significant experience in the development of workable health information technology systems in low-income countries, identify critical steps toward allowing developing countries to cross the "digital divide" to realize the full potential of e-health to improve the quality and efficiency of their health care systems.

17 Feb 2010

Researchers discover new strategy to overcome drug resistance in breast cancer

Combining tamoxifen, the world's most prescribed breast cancer agent, with a compound found in the flowering plant feverfew may prevent initial or future resistance to the drug, say researchers at Georgetown Lombardi Comprehensive Cancer Center.

17 Feb 2010

New book by 12 world-leading scientists calls for renewed approach to drug policy

Drug policy - or really, the way our society controls and provides interventions for both legal and illegal psychoactive substances - is one of those things that seems inherently controversial.

17 Feb 2010

Educational event: SCAI highlights gender and racial disparities in treating cardiovascular disease

The Society for Cardiovascular Angiography and Interventions (SCAI) today announced an educational event for the public highlighting the gender and racial disparities in the prevention and treatment of cardiovascular disease. The "Know What Counts" educational program titled, "The Path to Health Care Equity: Identifying and Solving Racial, Ethnic, and Gender Disparities in Health Care in the New Century," will feature a distinguished physician panel, along with a keynote address by U.S. Senator Ben Cardin.

17 Feb 2010

Phase II clinical trial result of abiraterone drug shows promise for advanced prostate cancer

New results from a phase II clinical trial of the prostate cancer drug abiraterone suggest that it may help men with advanced disease who have tried standard treatments.

17 Feb 2010

Research suggests scorpion venom could be an alternative to morphine painkiller

Scorpion venom is notoriously poisonous ― but it might be used as an alternative to dangerous and addictive painkillers like morphine, a Tel Aviv University researcher claims.

17 Feb 2010

Medicine News and Research

Media examine efforts to eradicate Guinea worm

BG Medicine, Merck collaborate in development of novel biomarker for lipid disorder management

Obesity doubles the risk of developing kidney stones: Study

People who are happy and content are less likely to develop heart disease

AGHE to hold conference to discuss on gerontological and geriatric education and training

Utah tries to improve state health insurance exhange; Mich. plans for doctor shortage

Sorafenib drug therapy can reduce the size of primary kidney tumors before surgery

New research units established for Japanese-German research collaboration

Ardiem Medical receives non-exclusive license to make and sell neuromodulation devices

NABsys to utilize $7M Series B funding for accelerating DNA sequencing platform development

FDA approved cannabis medicines needed for veterans to relieve symptoms of PTSD

NCOA survey: Communication about safety of medical imaging for patients is often inadequate

AAFA launches national PSA on "Two Main Causes of Asthma"

Eleven Biotherapeutics announces completion of $35M Series A funding

Low-income nations lack advanced e-health tools that can help them achieve better health outcomes

Researchers discover new strategy to overcome drug resistance in breast cancer

New book by 12 world-leading scientists calls for renewed approach to drug policy

Educational event: SCAI highlights gender and racial disparities in treating cardiovascular disease

Phase II clinical trial result of abiraterone drug shows promise for advanced prostate cancer

Research suggests scorpion venom could be an alternative to morphine painkiller

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News